Literature DB >> 18026704

Successful local antiproliferative paclitaxel delivery in a repeatedly restenosed lesion of the right coronary artery after drug eluting-stent implantation.

C Herdeg, K Göhring-Frischholz, U Helber, T Geisler, A May, K K Haase, M Gawaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18026704     DOI： 10.1007/s00392-008-0604-6

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  10 in total

1.  Visualization and comparison of drug effects after local paclitaxel delivery with different catheter types.

Authors:  C Herdeg; M Oberhoff; A Baumbach; A Blattner; A Küttner; S Schröder; K K Haase; K R Karsch
Journal:  Basic Res Cardiol       Date:  1999-12       Impact factor: 17.165

2.  Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.

Authors:  J Wöhrle; T Nusser; H A Kestler; M Kochs; V Hombach
Journal:  Clin Res Cardiol       Date:  2006-12-08       Impact factor: 5.460

3.  Debating the risks of drug-eluting stents.

Authors:  Miriam Shuchman
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

4.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

Authors:  Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

5.  Incidence and predictors of target vessel revascularization after sirolimus-eluting stent treatment for proximal left anterior descending artery stenoses among 2274 patients from the prospective multicenter German Cypher Stent Registry.

Authors:  Ahmed A Khattab; Christian W Hamm; Jochen Senges; Ralph Toelg; Volker Geist; Tassilo Bonzel; Malte Kelm; Benny Levenson; Christoph A Nienaber; Georg Sabin; Ulrich Tebbe; Steffen Schneider; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2007-02-26       Impact factor: 5.460

6.  The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry.

Authors:  Ralf Zahn; C W Hamm; S Schneider; U Zeymer; G Richardt; M Kelm; B Levenson; T Bonzel; U Tebbe; G Sabin; C A Nienaber; Thomas Pfannebecker; J Senges
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

Review 7.  Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.

Authors:  J Carlsson; B von Wagenheim; R Linder; T M Anwari; J Qvist; I Petersson; T Magounakis; B Lagerqvist
Journal:  Clin Res Cardiol       Date:  2006-12-22       Impact factor: 5.460

8.  Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo.

Authors:  C Herdeg; M Oberhoff; A Baumbach; A Blattner; D I Axel; S Schröder; H Heinle; K R Karsch
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

9.  Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery.

Authors:  D I Axel; W Kunert; C Göggelmann; M Oberhoff; C Herdeg; A Küttner; D H Wild; B R Brehm; R Riessen; G Köveker; K R Karsch
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

10.  Local paclitaxel delivery after coronary stenting in an experimental animal model.

Authors:  Christoph Dommke; Karl K Haase; Tim Süselbeck; Ines Streitner; Dariush Haghi; Jürgen Metz; Martin Borggrefe; Christian Herdeg
Journal:  Thromb Haemost       Date:  2007-09       Impact factor: 5.249
  10 in total
  3 in total

1.  Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008. (PEPCAD, LokalTax, INH, German ablation registry, German device registry, DES.DE registry, DHR, Reality, SWEETHEART registry, ADMA, GERSHWIN).

Authors:  L S Maier; C Maack; O Ritter; M Böhm
Journal:  Clin Res Cardiol       Date:  2008-04-25       Impact factor: 5.460

2.  Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting.

Authors:  Dimas T Ikeoka; Carolina Z Vieira; Pedro A Lemos; Tania V Strabelli; Expedito E Ribeiro da Silva; Marco A Perin; Andrea Groselj-Strele; Beate Tiran; Andreas Tiran; Bruno Caramelli
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

3.  Reduction of neointimal hyperplasia in porcine coronary arteries by 2-deoxy-D-glucose.

Authors:  Holger M Nef; Helge Möllmann; Astrid Joseph; Christian Troidl; Sandra Voss; Maximilian Rauch; Ralf Kinscherf; Achim Vogt; Michael Weber; Christian W Hamm; Albrecht Elsässer
Journal:  Clin Res Cardiol       Date:  2009-05-07       Impact factor: 5.460
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.